Meet the team

INTELLECTUAL PROPERTY

Posse Herrera Ruiz

Barranquilla, Colombia
+2 other locations
  • Bogota, Colombia
  • Medellin, Colombia
View firm profile

Deals

SOLLA S.A.

We handle Solla’s trademark portfolio in Colombia and abroad.

We would like to highlight the prejudicial negotiation of the infringement of Solla’s key trademarks Nutrecan and Nutrecat by Puertomar S.A. and avoided filing an infringement action and are seeking to execute a settlement agreement very shortly.

We also secured registration for another key trademark, Sabueso el de todas las razas & design in class 31, despite of an opposition filed by Alimentos Concentrados Raza LTDA. on the grounds of its trademark Raza by successfully proving that the conflicting trademarks were sufficiently different and there was no bad faith from our client.

TEAM FOODS COLOMBIA S.A.

We handle Team’s trademark portfolio in Colombia as well as some matters abroad.

We obtained the notoriety of trademark Dagusto for the first time in the Colombian market by successfully opposing the registration of trademark Buengusto & design in classes 29 and 30 filed by Restrepo Hermanos S.A.

We also obtained the extension of notoriety of trademark Gourmet by opposing against trademark Estado Gourmet, as well as the acknowledgement of the existence of the trademark family Gourmet.

FENDER MUSICAL INSTRUMENTS CORPORATION

We have obtained the registration of key trademarks FENDER PLAY and STUDIOLIVE.

Currently, we are seeking to overturn the denial of trademark ERIS on the grounds of trademark ARIS in class 9 owned by Diego Alejandro Aristizábal García by proving that ERIS and ARIS may coexist in view of the orthographic, phonetic and graphic differences provided by their different letters E and A, allowing consumers to distinguish them.

Additionally, that ARIS coexists with trademark ARUS (having only one different letter).

 

CARDIX THERAPEUTICS, LLC

The present invention relates to a pharmaceutical composition for treating or ameliorating bradycardia or cardiovascular disease.

To overcome the deficiencies associated with current treatments of bradycardia there are methods and pharmaceutical compositions useful for treating bradycardia and associated cardiovascular diseases.

The Colombian Patent Office issued the Resolution with the Notice of allowance.

ALLIANCE VASCULAR DEVICES LLC. THROUGH WAGENKNECHT IP LAW GROUP, PC

The present invention refers to medical infusion device commonly used in hospitals and medical care facilities to administer chemotherapy, provide intravenous fluids, and transfuse blood. Typically, these devices are used to administer treatments through a medical port implanted under the skin and connected to a catheter. Accessing the medical port involves inserting the non-coring needle into a septum at the top of the port. The septum is capable of resealing after removal of the non-coring needle, thereby allowing multiple uses of a same port.

The invention is a medical infusion device that prevents or reduces needle stick injuries and exposure to infusion media by leaks or spillage once the needle is withdrawn from the patient.

The Mexican Patent Office issued the Resolution with the Notice of allowance.

Organigram

Name Post Phone Mail Send email

Team Services

The present invention relates to a pharmaceutical composition for treating or ameliorating bradycardia or cardiovascular disease.

To overcome the deficiencies associated with current treatments of bradycardia there are methods and pharmaceutical compositions useful for treating bradycardia and associated cardiovascular diseases.

The Colombian Patent Office issued the Resolution with the Notice of allowance.

Posse Herrera Ruiz’s Intellectual Property practice area has a true understanding of the issues involved in handling complex global patent and trademark portfolios. That is why it offers a proven, successful, business-oriented and cost-efficient centralized service for IP filing and prosecution in Latin-American and Caribbean countries, through a one-stop value generating solution.